Searched for
SANOFI HEALTHCARE
Sanofi healthcare receives CDSCO approval for Qftilia therapy for haemophilia patients in IndiaSanofi Healthcare has obtained authorisation from the Central Drugs Standard Control Organisation for Qfitlia. This therapy is designed to ...- Medico Remedies among 5 Healthcare stocks hitting 52-week low; slipped up to 48% in a monthThe Sensex fell 242 points to 72,529 as five BSE Healthcare Index stocks touched fresh 52-week lows. Medico Remedies, Pfizer, AstraZeneca P...
- Sanofi Healthcare buys 15.2% stake in Sanofi India for Rs 1,068 croreSanofi Healthcare India acquired a significant 15.2 percent stake in Sanofi India through an open market transaction. The company purchased...
- European pharma chiefs warn region risks losing ground to America, ChinaDrugmakers for months have been warning they could curtail investments and delay the release of new medications in Europe, widening a dispa...
- Sun Pharma among 9 pharmaceutical firms to lower drug prices for Americans, Trump saysNine pharmaceutical firms reached deals with the Trump administration for lower drug prices. These agreements expand the total number of co...
- Can AI shorten India's rare disease diagnosis journey? New tool aims to do just thatSanofi has launched AccelRare, an AI tool aiding doctors in rare disease pre-diagnosis. This platform generates potential diagnoses within ...
- Sanofi Consumer Healthcare shares zoom 14% after Q4 profit jumps 50%; declares dividend of Rs 75Sanofi Consumer Healthcare shares surged over 14% following a robust 50% year-on-year net profit increase to Rs 66.5 crore in Q4. Driven by...
- Dr Reddy's to introduce Sanofi's novel drug in IndiaDr. Reddy's Laboratories has expanded its partnership with Sanofi Healthcare to introduce Beyfortus, a novel drug preventing lower respirat...
- Sanofi Health leases office space in Hyderabad"The monthly rental is set at ?75 per sq ft, amounting to a total of ?2.05 crore. A security deposit equivalent to 7.5 months of rent, valu...
- CD&R makes Rs 2,983 cr open offer for 26% stake in Sanofi Consumer Healthcare IndiaGlobal investment firm CD&R announces an open offer to acquire a 26% stake in Sanofi Consumer Healthcare India for up to Rs 2,983 crore. Th...
- Dispute with Sanofi settled, Panacea scrip soars to over 3-yr highPanacea Biotec has settled a patent dispute with Sanofi Healthcare India, leading to a rise in its stock. The Delhi High Court case involve...
- Panacea, Sanofi settle patent litigation over hexavalent vaccinePanacea Biotec has settled a patent infringement case with Sanofi Healthcare India over a hexavalent vaccine. Sanofi will not launch its Sh...
- Sanofi Consumer Healthcare lists on stock exchanges after demerger, shares hit 5% upper circuit on day 1Shares of Sanofi Consumer Healthcare India made their market debut on Friday, listing on both the NSE and BSE. On its first day of trading,...
- Sanofi to invest Euro 400 mn in its Hyderabad GCC by 2030Sanofi Healthcare India Pvt Ltd plans to invest €400 million in its Hyderabad Global Capacity Centre (GCC) over six years, including €100 m...
- Dr Reddy's to promote, distribute Sanofi vaccine brands in IndiaThe announcement comes a day after Sanofi Healthcare India announced a separate partnership with Cipla to boost access to Sanofi's central ...
- Sanofi board approves demerger of its consumer healthcare businessThis decision will open new gates for the India business and employees in a value-driven move to accelerate growth for both the pharmaceuti...
- Sanofi, Boehringer Ingelheim close business swap in IndiaSanofi is excited to embrace the incoming CHC brands and people associated with this business, as this is in line with objective of boostin...
- Sanofi Aventis-Piramal deal falls through over valuationFrench pharmaceutical giant Sanofi Aventis’ proposed deal to acquire a majority stake in Mumbai-based Piramal Healthcare has fallen through...
- Sanofi Aventis's Piramal plans fall throughFrench pharma major Sanofi Aventis's plans to acquire a majority stake in Mumbai-based Piramal Healthcare has fallen through due to differe...
- Sanofi seen ahead in Piramal raceSanofi-Aventis has completed due diligence and the deal could be closed soon, one of the two persons told ET on condition of anonymity.
Load More
